InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: bas2020 post# 324610

Thursday, 08/05/2021 1:15:56 PM

Thursday, August 05, 2021 1:15:56 PM

Post# of 463626
No, I am dismissing the influence that Rett org has with the FDA when it comes to advancing Rett treatments ahead of any other ones, each of which have their own foundations dedicated to helping their patients and ability to advocate to the FDA decision-makers.

Putting aside your financial interest in Anavex, what makes Rett syndrome more important than, say, the diseases that other rare disease biotechs are focusing on? Allievex, NeuroVive, there are dozens of companies just like Anavex.

The Rett Foundation can advocate for accelerated approval all it wants. I don't think it'll receive it because Rett is competing with a bunch of other really horrific diseases and there is limited manpower at the FDA to accelerate the timelines for all of them.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News